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Immune-associated genesAKR/J mice carrying leukemia viral inserts develop thymic lymphoma. Recently, we demonstrated that the
incidence of thymic lymphoma was decreased when these mice were raised in a low-dose-rate γ-irradiation
facility. In contrast, mice irradiated at a high-dose rate developed severe thymic lymphoma and died much
earlier. To understand the genetic changes occurred by low- versus high-dose-rate γ-irradiation whole
genomemicroarray was performed. Both groups of mice demonstrated up-regulation of Ifng, Igbp1, and IL7 in
their thymuses, however, mice exposed to high-dose-rate γ-irradiation exhibited marked down-regulation of
Sp3, Il15, Traf6, IL2ra, Pik3r1, and Hells. In contrast, low-dose-rate irradiated mice demonstrated
up-regulation of Il15 and Jag2. These gene expression proﬁles imply the impaired immune signaling
pathways by high-dose-rate γ-irradiation while the facilitation of anti-tumor immune responses by
low-dose-rate γ-irradiation. Therefore, our data delineate common and distinct immune-associated
pathways downstream of low- versus high-dose-rate irradiation in the process of cancer progression in
AKR/J mice.t.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.1. Introduction
High-dose and high-dose-rate ionizing radiations have been
shown to be detrimental, causing apoptosis [1,2] and transformation
of normal cells into tumor cells [3]. High-dose radiation also impairs
immune functions, leading to the defects in the removal of damaged
or tumor cells, and allows accumulation of DNA mutations [4]. In
contrast, low-dose (≤0.2 Gy) of X- or γ-ray irradiation has been
reported to exert various beneﬁcial effects in living organisms,
including augmentation of immune functions [5–7], prevention and
cure of diseases [8,9], and prolongation of life span [9,10].
A series of recent studies underscore the involvement of immuno-
logical changes in mice exposed to chronic low-dose-rate irradiation.
Ina and Sakai have demonstrated that the life span of autoimmune
MRL–lpr/lpr mice was signiﬁcantly prolonged upon chronic low-dose-
rate γ-irradiation (1.2 mGy/h for 3 weeks), which was accompanied by
the increased number of CD8+ T cells alongwith concomitant reduction
of detrimental CD3+CD45R/B220+ and CD40+CD45R/B220+ cells [9].
Ina et al. subsequently reported that radiation-induced thymic
lymphoma in C57BL/6 mice was suppressed by continuous exposure
of low-dose-rate (1.2 mGy/h for 258 days) γ-irradiation and demon-strated the involvement of immune activation in this process [10].
Similarly, we found that AKR/J mice developing spontaneous thymic
lymphoblastic lymphoma exhibited a lower degree of tumor incidence
and prolonged survival when exposed to a low-dose-rate γ-irradiation
at 0.7 mGy/h during their lifetime [11]. In contrast, mice irradiated at a
high-dose rate (0.8 Gy/min for 4.5 Gy) developed higher degree of
thymic lymphoma and died much earlier. By using whole-genome
microarray analysis, we identiﬁed the common genes associated with
the early stages of carcinogenesis in both high- and low-dose-rate-
irradiated mice. These genes include ones in the apoptotic pathway
(Cd5l, Fcgr3, and Pycard) and immune-associated pathway (Lilrb3, Igh-
6 (Ighm), Fcgr2b, and MGC60843). These data suggest that both high-
and low-dose-rate irradiation stimulated apoptotic signaling and
immune-triggering pathways, presumably as an effort to remove
transformed cells. Herein, we identiﬁed additional immune-associated
genes that were differentially regulated during the exposure of AKR/J
mice to low- versus high-dose-rate γ-irradiation. Low-dose-rate γ-
irradiation speciﬁcally up-regulated Jag2, a notch ligand involved in the
development of T, B and NK cells, and Il15, a cytokine that stimulates T
and NK cell function, without signiﬁcantly affecting other immune-
associated genes. In contrast, high-dose-rate γ-irradiation resulted in
dramatic down-regulation of the immune signaling components
necessary for activating T, B, and NK cells. Therefore, the uncontrolled
growth of thymic lymphoma seen in high-dose-rate-irradiated mice
might have likely been, in part, due to the decreased expression of
immune-associated genes. On the other hand, chronic low-dose-rate
Table 1
Survival and thymic lymphoma incidence in high- and low-dose-rate irradiated AKR/J
mice.
Exposure Survival daysa Thymic lymphoma (%)b
Non-irradiation 230±8.0 85
High-dose-rate irradiation 208±9.0 95
Low-dose-rate irradiation 243±12.8 70
a The mean survival rates of irradiated mice were analyzed using the Kaplan–Meier,
Wilcoxon method (n=90/group).
b Cumulative incidence of thymic lymphoma were counted after irradiation (n=90/
group).
359S.C. Shin et al. / Genomics 97 (2011) 358–363irradiation appeared to limit transformation/gene mutation process via
concurrent activation of genes involved in the apoptosis and immune
cell activation.
2. Materials and methods
2.1. Animals
Seven-week-old female AKR/J mice were purchased from Shizuoka
Laboratory Center (Japan) and kept under speciﬁc-pathogen-free
conditions. Animals were maintained in a room at a temperature of
23±2 °C and relative humidity of 50±10%, with a 12-h lighting
schedule (200–300 Lux; 8:00 AM to 8:00 PM). After one-week
adaptation period, 5micewere placed in a polycarbonate cage provided
with γ-sterilized pellets and autoclavedwater ad libitum. All the studies
were reviewed by the Institutional Animal Care and Use Committee at
Radiation Health Research Institute (RHRI) of Korea Hydro and Nuclear
Power Company and the mice were treated in accordance with the
governmental guidelines and the guidelines of RHRI. Themice used had
approximately equal body weights at the start of the experiments.
2.2. High- and low-dose-rate irradiation
A γ-ray generator (IBL 147 C; CIS Bio-International, France) was
used for generating high-dose-rate irradiation (
137
Cs, 0.8 Gy/min).
Mice were irradiated for the total dose of 4.5 Gy, which was selected
according to the report by K. Yoshida [12]. High-dose-rate irradiated
mice were returned to their cages after irradiation. To evaluate the
effect of low-dose-rate irradiation on the incidence of thymic
lymphoma, we reared mice in a long-term low-dose-rate irradiation
facility equipped with
137
Cs source and exposed them at 0.7 mGy/
h until the cumulative dose reached 4.5 Gy. Each experimental group
comprised 30 mice, and the entire experiment was repeated 3 times.
Non-irradiated mice were maintained under the same condition as
experimental groups, except that radiation was not given.
2.3. Survival rate and incidence of thymic lymphoma
The survival rate and tumor incidence in AKR/J mice exposed to
low- versus high-dose-rate γ-irradiation were determined as de-
scribed previously [11]. Mice started to die between 3 and 4 months
after birth. Dead mice or mice bearing thymic tumors when their
thymus weighed more than twice, due to naturally occurring
thymoma, were autopsied and stained with hematoxylin and eosin
for histological examination [13].
2.4. Whole genome microarray analysis
Whole genome microarray was performed with the thymus
collected on the 130th day after irradiation, as described previously
[11]. Normal-sized thymuses from 130-day-old mice after high- and
low dose-rate irradiation were collected and analyzed by whole
genomic microarray using an Agilent oligo microarray (44K, 60-mer
oligonucleotide). Microarray slides were scanned with a GenePix
4000B scanner (Axon Instruments, San Diego, CA), and the scanned
images were analyzed using GenePix v6.0 software to obtain the
signal intensity of spots. Raw data were normalized by the median
normalization method.
2.5. Statistical analysis
The survival rate of mice exposed to high- and low-dose-rate
radiation was analyzed using the Kaplan–Meier test and the Wilcoxon
method. The incidence of thymic lymphoma was compared across the
experimental groups using the statistical program SAS (ANOVA,
Student's t-test). One sample t-test was performed with SPSS software(SPSS, Chicago, IL) for the gene expression analysis. Where P value was
less than 0.05, the result was considered signiﬁcant.
3. Results
3.1. Survival and cancer incidence in high- and low-dose-rate irradiated
mice
AKR/J mice raised in a low-dose-rate γ-irradiation facility
displayed higher survival rate than those not irradiated or exposed
to high-dose-rate γ-irradiation (Table 1). Statistical analyzes showed
that the life-span of low-dose-rate irradiated mice (243±12.8 days)
was signiﬁcantly longer than those of high-dose-rate irradiated
(208±9.0 days, pb0.05) or non-irradiated mice (230±8.0 days,
pb0.05). In accordance with the survival rate, the incidence of thymic
lymphoma was signiﬁcantly lower in mice reared in a low-dose-rate
γ-irradiation environment than in non-irradiated or high-dose-rate
γ-irradiation facility (Table 1). Therefore, a high-dose of ionizing
γ-radiation was found to facilitate tumor growth while a low-dose of
radiation inhibited tumor progression in AKR/J mice spontaneously
developing thymic lymphoma.
3.2. Differential expression of immune-associated genes in the thymus of
high- versus low-dose-rate γ-irradiated mice
Whole-genome microarray analysis, using thymic mRNAs
obtained on the 130th day after irradiation, demonstrated 695 up-
regulated and 1726 down-regulated genes in the high-dose-rate
irradiated mice and 410 up-regulated and 198 down-regulated genes
in the low-dose-rate irradiated mice (Fig. 1A). Among these genes,
those whose expression levels underwent ≥2-fold changes upon
irradiation were selected and categorized into 9 groups according to
their molecular functions. As shown in Fig. 1B, while the high-dose-
rate irradiation affected the wide range of genes in all 9 groups, those
altered by chronic low-dose rate irradiation were limited to and
mostly seen in the pathway of apoptosis and T- and B-cell activation.
Consistent with our previous results [11], the apoptosis-regulating
genes, Cd5l, Fcgr3, and Pycard, and the immune-associated genes,
Lilrb3, Igh-6 (Ighm), Fcgr2b, Fcgr3, and MGC60843 were conﬁrmed to
be commonly elevated in both high- and low-dose-rate irradiated
mice (Fig. 2). Additionally, we found that Ifng, Igbp1, and IL7, genes
known to stimulate immune function and survival, were elevated in
both groups of mice (Fig. 3). These data demonstrate that γ-
irradiation, regardless of the doses, promoted expression of genes
involved in the apoptotic and immune-associated signaling pathways.
Strikingly, we observed speciﬁc up-regulation of Jag2, a notch ligand,
and Il15, a potent cytokine for T and NK cells, in the thymus of low-
dose-rate irradiatedmice while no such up-regulation was seen in the
high-dose-rate irradiated mice (Figs. 3–4). Mice exposed to high-
dose-rate γ-irradiation further exhibited marked down-regulation of
diverse immune-associated genes, Sp3, Il15, Traf6, IL2ra, Pik3r1, and
Hells (Fig. 4). None of these geneswere found to be down-regulated in
low-dose-rate irradiated mice. Interestingly, the expression of Cd3e,
Rag2, CD28, Cbfb, Cxcr4, and Ppp3cb was also decreased in the high-
Fig. 1. Gene expression proﬁles in the thymus upon high- and low-dose-rate irradiation. A, Whole genome microarray was performed with the thymus collected on the 130th day
after irradiation, as described under the Materials and methods. Using this screening method, 695 genes were found to be up-regulated and 1726 genes were down-regulated in the
high-dose-rate irradiated mice while 410 genes were up-regulated and 198 genes were down-regulated in the low-dose-rate irradiated mice. B, Two fold up- or down-regulated
genes at 130 days after irradiation were grouped according to their molecular functions. DNA repair-genome instability (A), DNA damage signaling pathway (B), cell cycle (C), cancer
pathway ﬁnder (D), p53 signaling pathway (E), apoptosis (F), and T- and B-cell activation (G).
360 S.C. Shin et al. / Genomics 97 (2011) 358–363dose-rate irradiated mice; however, reduction was also noted in mice
exposed to low-dose-irradiation. Hence, these genes did not appear to
be selectively regulated by high- or low-dose-rate irradiation. The gene
expression proﬁles seen here imply concurrent activation of apoptosisGene
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Fig. 3. Immune-associated genes commonly up-regulated in the high- versus low-dose-rate-irradiated AKR/J mice. The fold increase in the expression of immune-associated genes in
high- and low-dose-rate irradiated mice, shown in the box (A), was plotted as a bar graph (B). * indicates a gene (Jag2) undergoing signiﬁcant up-regulation upon low dose-rate
irradiation as compared to the high-dose-rate irradiation.
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Fig. 4. Immune-associated genes down-regulated in the high- versus low-dose-rate-irradiated AKR/J mice. The fold decrease in the expression of immune-associated genes in high-
and low-dose-rate irradiated mice, shown in the box (A), was plotted as a bar graph (B). * indicates genes signiﬁcantly down-regulated in the high-dose-rated irradiation as
compared to the low-dose-rate irradiation. ** indicates a gene whose expression was inversely regulated by the low- versus high-dose-rated irradiation. While expression of IL-15
was severely down-regulated by high-dose-rate irradiation, it was signiﬁcantly up-regulated by low-dose-rate irradiation.
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Fig. 5. Schematic representation of molecular events occurring following low- versus high-dose-rate irradiation. A, Common genes activated in both high- and low-dose-rate
irradiated AKR/J mice were shown. Exposure to γ-irradiation, regardless of the dose-rate, unequivocally stimulated both apoptotic and immune-triggering pathways. B, Differential
gene expression proﬁle in high- versus low-dose-rate irradiated AKR/J mice. Both high- and low-dose-rate irradiation stimulated immune-associated genes, Ifn-g, Igbp1, and Il7.
Expression of Ifn-g, Ifbp-1, and Il7 along with Jag2 and Il15 in low-dose-rate irradiated mice might have successfully driven anti-tumor immune responses against transformed cells
and hence inhibited tumor growth (left panel). However, drastic down regulation of Sp3, Il15, Traf6, Il2ra, Pik3r1, and Hells in the high-dose-rate irradiated mice might have
prevented the development of appropriate anti-tumor immune responses and contributed to tumor progression.
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and inhibited tumor growth (Fig. 5B). Therefore, ionizing γ-irradiation
differentially regulates expressionof immune-associatedgenesdepend-
ing on the dose-rate and total doses exposed. This may account, in part,
for the beneﬁcial or detrimental effects seen in low- versus high-dose-
rate irradiated AKR/J mice.
4. Discussion
Radiation-induced transformation process and cancer incidence
have long been studied in experimental animals. AKR/J mice carrying
inserted murine leukemia viral oncogenes develop thymic lympho-
ma at later periods of life and eventually die [14,15]. It is well known
that the viral oncogene insert in the thymus of AKR/J mice acts as an
initiator of tumor processing. If the damaged DNA in AKR/Jmice is not
repaired properly, carcinogenesis is triggered. Apoptosis- and
immune-associated functional genes are likely to be activated during
tumor progression to remove damaged and/or cancerous cells. The
DNA damage in the thymocytes of AKR/J mice is further enhanced by
exposure to high-dose and high-dose-rate radiation. On the other
hand, in mice exposed to low-dose and low-dose-rate radiation, the
number of thymocytes showing efﬁcient DNA repair was found to be
higher [16]. In line with these reports, our data showed that low-
dose-rate irradiated AKR/Jmice had low thymic lymphoma incidence
and prolonged life span. These changes were likely to occur at the
cellular and molecular levels [17,18], which might have eventually
affected the rate of tumor progression and survival.
In accordance with these ﬁndings, multiple genes were found to be
up-regulated in both high- and low-dose-rate-irradiated mice; these
common genes included ones in the apoptotic pathway (Cd51, Fcgr3,
Pycard) and genes involved in leukocytes and lymphocytes activation
pathways (Lilrb3, Igh-6 (Ighm), Fcgr2b, Fcgr3, and MGC60843) [11].
These results indicated that upon irradiation, regardless of high- or low-dose-rate, apoptotic and immune signaling pathways were concurrent-
ly triggered as aneffort to eliminate transformed cells carryingdamaged
DNAs (Fig. 5A). Our microarray analysis conﬁrmed that genes
responsible for T and B cell activation were expressed in the thymus
of both high- and low-dose-rate-irradiated mice. The genes related to
the activation of IgM (Igh-6 (Ighm), MGC60843), IgG (Fcgr2b and
Fcgr3), and leukocytes (Lilrb3) were found to be up-regulated in both
high- and low-dose-rate irradiatedmice. Up-regulation of Igh-6 (Ighm)
(marker of Pro-B cells) and MGC60843 [19,20] indicated that tumor-
speciﬁc antibodiesmight havebeengeneratedby the activation of B-cell
progenitors in the thymic cortex. Fcgr2b (FcgammaRIIB) and Fcgr3
(FcgammaRIII), genes that were known to stimulate antigen presenting
cells at the early stage of inﬂammatory immune responses [21], were
alsoup-regulated. The expression of Lilrb3 (leukocyte immunoglobulin-
like receptor B3), one of the immunoregulatory receptor-coding genes
shown to quickly remove cancer cells, was found to be elevated [22]. In
addition, the pro-inﬂammatory cytokine, Ifng (interferon-gamma) [23],
the early T cell development-related gene Igbp1 (immunoglobulin
binding protein 1) [24], and the T and B cell lymphocyte development-
related gene Il7 (interleukin 7) [25]were similarly up-regulated in both
high- and low-dose-rate irradiated mice. These data imply that γ-
irradiation, regardless of the dose-rates, generated pro-inﬂammatory
responses to activate immune system, presumably as a natural
protection mechanism.
Interestingly, we found that Jag2 (Jagged2), a notch ligand, was
speciﬁcally up-regulated in the low-, but not high-, dose-rate
irradiated mice. Jag2 plays an important role in the development of
T, B, and NK cells, hence, increased Jag2 expression in the low-dose-
rate irradiated mice may also reﬂect the promotion of anti-tumor
immune responses within the thymus [26]. Furthermore, the level of
Il15, a potent cytokine for T and NK cells [27], was also elevated, thus
these genes might have driven strong immune responses within the
thymus. Therefore, both cellular and humoral immune responses
363S.C. Shin et al. / Genomics 97 (2011) 358–363were turned on in the low-dose-rate irradiated mice, leading to
elimination of damaged DNA and cancerous cells. Schematic diagrams
representing these phenomena are illustrated in Fig. 5.
Unlike low-dose-rate, high-dose-rate irradiation caused down-
regulation of multiple immune-associated genes (Fig. 3); Sp3 (trans-
acting transcription factor 3) [28] to inhibit tumor development by
inducing apoptotic pathway, Il15 (interleukin 15) [27] that stimulates
T and NK cells, Traf6 (TNF receptor-associated factor 6) [29] that
induces immune responses after recognizing damaged or cancer cells,
Il2ra (Interleukin 2 receptor, alpha chain) [30], an IL-2 receptor alpha
chain that serves as a T and NK cell activation marker, Pik3r1
(phosphatidylinositol 3-kinase regulatory subunit p85α) [31], a gene
involved in the development of colon cancer, and Hells (helicase,
lymphoid speciﬁc) [32]. Together, these gene expression proﬁles
imply that cellular immunitywas severely impaired by high-dose-rate
radiation and contributed to the acceleration of thymic lymphoma
growth. Notably, the expression of additional immune-associated
genes, Cd3e, Rag2, CD28, Cbfb, Cxcr4, and Ppp3cb, was also found to
be decreased in the high-dose-rate irradiated mice, however, similar
or slightly lesser degree of reduction was also noted in mice exposed
to low-dose-irradiation. Hence, these genes did not appear to be
selectively regulated by high- or low-dose-rate irradiation.
In conclusion, our data highlight the common and distinct signaling
pathways operating downstream of low- versus high-dose-rate irradi-
ation during the process of tumor development and progression in AKR/J
mice. Our data also suggest that while tumor cells might have been
eliminated via activation of apoptosis and immune related events in both
high- and low-dose-rate irradiatedmice, these processeswere not found
to be sufﬁcient in thehigh-dose-irradiatedmicedue to concurrentdown-
regulation of diverse immune-associated genes. Therefore, these data
provide signiﬁcant insight into the molecular basis underlying low-
versus high-dose irradiated molecular events and further presents the
therapeutic opportunity inmanydisease conditions including cancer and
immunosuppressive diseases by low-dose-rate radiation.
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